INTRODUCTION
Aspartylglycosaminuria (aspartylglucosaminuria, AGU) is a rare inherited disorder of asparagine-linked glycoprotein catabolism (Jenner and Pollitt, 1967; Pollitt et al., 1968) . Lysosomal glycosylasparaginase (EC 3.5.1.26) , the deficient enzyme in AGU, is responsible for hydrolysing the amide bond of the GlcNAc-Asn carbohydrate-to-protein linkage (Aronson and Kuranda, 1989) . Absence of glycosylasparaginase activity in AGU-affected cells allows aspartylglucosamine to accumulate as the major end-product of glycoprotein degradation within lysosomes. The large quantities of stored aspartylglucosamine and related minor fragments dramatically alter cell morphology and ultimately retard the physical and mental development of patients with AGU (Durand and O'Brien, 1982; Beaudet, 1983) . Since the first report of AGU in two British siblings (Jenner and Pollitt, 1967; Pollitt et al., 1968) , over 200 cases have been documented, with all but a few being individuals of Finnish descent (Palo and Mattsson, 1970; Autio, 1972; Autio et al., 1973) . The estimated occurrence of AGU in Finland is 1:3600 with the carrier frequency predicted to be as high as 1:30 (Mononen et al., 1991a) . Besides the original two British cases there have since been other reports of AGU in ethnically diverse patients outside Finland (Gehler et. al., 1981; Hreidarsson et al., 1983) ; however, the current number is less than 15.
As a first step to studying the molecular genetics of AGU, the human glycosylasparaginase cDNA sequence was determined by our laboratory (Fisher et al., 1990) . The cDNA encodes a 46 kDa precursor polypeptide that is post-translationally processed to a heavy (24 kDa) and light (18 kDa) subunit. (The 24 kDa subunit cells revealed the paternal Ala-+ Val amino-acid substitution destroyed glycosylasparaginase catalytic activity, prevented transport of the mutant protein to the lysosome, and prevented maturation of the enzyme precursor to its native subunit structure.
The Ala --Val mutation therefore affects glycosylasparaginase in a manner similar to the Finnish AGU Cys -+ Ser substitution, further supporting a linkage of glycosylasparaginase catalytic activity to its lysosomal transport and subunit processing [Fisher and Aronson (1991) J. Biol. Chem. 266, 12105-12113] . In addition, a 5 bp deletion mutation from an American patient with AGU has been characterized. The deleted sequence occurs at the beginning of the glycosylasparaginase coding sequence, resulting in an extremely truncated polypeptide. The American 5 bp deletion and the British maternal 7 bp deletion possibly decrease mRNA stability.
of human glycosylasparaginase has most often appeared in the literature as a or heavy, while the 18 kDa subunit has been referred to as or light. In an effort to establish consistency in the literature, we are adopting the usage of heavy and light to describe the subunits of glycosylasparaginase in this and subsequent publications.) We have also characterized the human glycosylasparaginase gene (AGU) and found it to be 13 kb with the open reading frame distributed among nine exons (Park et al., 1991) . The most refined localization of the human gene to chromosome 4q32-q33 has been done recently by in situ hybridization (Morris et al., 1992) . Using the collective cDNA and genomic AGU sequence information, the high frequency of AGU in Finland has been shown to be due to a single point mutation that causes a Ser substitution in the heavy subunit (Ikonen et al., 1991a; Mononen et al., 1991b; Fisher and Aronson, 1991a) . Expression studies in COS-l cells indicate the loss of Cys-163 not only causes enzymic inactivation of glycosylasparaginase, but also prevents the precursor polypeptide from being both correctly transported to the lysosome and processed to its mature subunits (Fisher and Aronson, 1991a,b) . The loss of lysosomal transport, subunit processing, and enzyme activity caused by the Finnish Cys-163
Ser substitution led us to propose that the three events are interrelated, with subunit maturation being a required step for glycosylasparaginase activity (Fisher and Aronson, 1991a,b) . Interestingly, Thr-206, which post-translationally becomes the N-terminal residue of the light subunit, has been implicated as an active-site residue since it forms a covalent linkage with an active-site-directed inhibitor of glycosylasparaginase (Kaartinen et al., 1991 (Fisher and Aronson, 1991a) . At the time this manuscript was being prepared, Ikonen et al. (1991b) reported candidate mutations from a collection of nonFinnish AGU cell lines. Among them was a British patient (M.A.) who was proposed to be a compound heterozygote. Both AGU allele mutations occur in the region which encodes the heavy subunit, one having a 7 bp deletion and the second a point method (Chomczynski and Sacchi, 1987) . Genomic DNA was purified by the SDS/proteinase K/phenol/chloroform extraction method (Maniatis et al., 1982) .
PCR ampliffication of cDNA and genomic DNA Two sets of oligonucleotide primers (all primers were synthesized by the Pennsylvania State Biotechnology Institute, University Park, PA, U.S.A.), designated A and B, were used to amplify the glycosylasparaginase cDNA sequence encoded by AGU patients and carriers. The primers were designed such that they would generate overlapping fragments that together would span the entire glycosylasparaginase mature protein-coding region. The selected primer sequences are shown below with their 5' and 3'-ends numbered in parentheses according to the human placenta cDNA sequence where+ 1 is A of the translational initiation codon ATG (Fisher et al., 1990) : In the absence of expression studies the possibility of the Ala -. Val substitution being a neutral polymorphism cannot be ruled A third set of oligonucleotide primers, designated C, was designed to amplify the AGU genomic sequence surrounding a 5 bp deletion mutation that was discovered in exon 3 of patient TC79-886. The sense-strand primer was against sequence for exon 3 of the human AGU gene while the antisense-strand primer was against sequence from intron 3 (Park et al., 1991 PCR reactions were performed as described previously using the GeneAmp PCR reagent kit from Perkin-Elmer Cetus Instruments (Fisher and Aronson, 1991a) . The PCR template was either first-strand cDNA prepared from random hexanucleotide-primed RNA (primer sets A and B) or genomic DNA (primer set C). Amplified DNA fragments were resolved on an agarose gel, purified by electroelution into dialysis tubing, and sequenced either directly (Kusukawa et al., 1990) or subsequent to M13mpl8/19 cloning. Sequence determination was done using a Sequenase Version 2.0 DNA sequencing kit as recommended by the manufacturer (United States Biochemical).
Northern-blot analysis
Approx. 20,a1g of total RNA from AGU patient TC79-886 or control fibroblasts was resolved on a 1.2 % (w/v) agarose/2.2 % (w/v) formaldehyde gel. RNA was electroblotted from the gel on to a nylon membrane and the resulting blot hybridized with the full-length human placental glycosylasparaginase cDNA (Fisher et al., 1990) random-primed labelled with [5'-32P]dCTP to a specific activity of approx. 109 c.p.m./,ug of cDNA. Prehybridization, hybridization, and wash conditions were as described previously (Fisher and Aronson, 1991a (Cullen, 1987) . A pSVL construct containing the normal human placental glycosylasparaginase cDNA, HPAsn.6 (pSVL/ HPAsn.6), was also used in this study (Fisher and Aronson, 1991a) . Three separate transfections of each vector were performed. Cell lysates of test or mock-transfected cells were prepared by sonication at 48-72 h post-transfection, assayed for glycosylasparaginase activity and total protein, and analysed by Western blotting as described elsewhere (Fisher and Aronson, 1991a) . Immunofluorescent localization of transfected COS-1 cells was as described previously (Fisher and Aronson, 1991b) .
RESULTS
American AGU patient TC79-886 contains a 5 bp deletion in the AGU open reading frame Two glycosylasparaginase mRNAs of 1.5 kb and 2.3 kb have previously been shown to be expressed in human fibroblasts and are believed to arise from the utilization of alternative polyadenylation sites (Park et al., 1991; Fisher and Aronson, 1991a) . When total RNA from American AGU patient TC79-886 fibroblasts was subjected to Northern-blot analysis, the 1.5 kb and 2.3 kb glycosylasparaginase messages were evident, but they exhibited a broadened banding pattern compared with an RNA sample from a normal fibroblast culture (Figure 1 ). In addition, the combined quantity of glycosylasparaginase mRNA expressed by AGU patient TC79-886 was found to be approx.
200% of normal after standardization against 28S rRNA. The smeared appearance of the glycosylasparaginase mRNAs from TC79-886 cells cannot be attributed to the quality of RNA that was isolated from this patient with AGU since a second preparation of RNA revealed similar results (results not shown).
DNA-sequence analysis of the PCR products from AGU patient TC79-886 generated by primer sets A and B revealed a 5 bp deletion (ACACA) spanning bp positions 367-371 of the human cDNA sequence (Figure 2a ). The 5 bp deletion causes a shift in the AGU open reading frame, thus resulting in premature translational termination (Figure 2c ). No additional discrepancies compared with the normal cDNA were observed. Genomic DNA was isolated from TC79-886 fibroblasts and used with oligonucleotide primer set C (see the Experimental section) to PCR amplify the region of exon 3 that contains the 5 bp deletion, as well as a portion of intron 3. Direct sequencing of the 300 bp genomic product again revealed the 5 bp deletion (Figure 2b which causes an Ala-1O1 -*Val amino-acid substitution, and a maternal 7 bp deletion at the 5'-end of the heavy subunit, which causes a shift in reading frame and premature translational termination. The precise sequence that is deleted in the maternal allele is one of three possibilities due to the nature of the surrounding sequence. They are (99)TTGGCCC (105), (100)TGGCCCT (106), and (101)GGCCCTT (107), where the bp positions are given in parentheses (Figures 3a and 3c) . No mutations were found upon sequencing the primer-set-B PCR product from either father or mother (results not shown), and therefore the C-302 -. T transition and the 7 bp deletion are the only changes in parental glycosylasparaginase mRNAs.
Direct sequencing of the PCR product generated with primer set A from D.A. demonstrated the paternal heterozygous genotype for the C-302 -. T allele (Figure 3b ). The resulting sequencing gel revealed two populations of AGU sequences, one containing the normal cytosine nucleotide at bp position 302 and a second with the mutant thymine nucleotide. Direct sequencing was not performed with the primer-set-A PCR product from the mother P.A. It is of interest that the frequency of Ml 3 clones that carried the maternal 7-bp-deletion allele was much lower than the normal allele. For instance, only one of 12 Ml 3 clones of the primer-set-A product from P.A. that were sequenced contained the 7-bp-deletion mutation while the remaining 11 were normal. This unequal occurrence of mutant versus normal alleles was not noted for the paternal C-302 -+ T base change. AGUA-aVal allele, COS-1 cells were transfected with a pSVL expression vector construct containing either the normal human placental glycosylasparaginase cDNA (pSVL/HPAsn.6) or the mutant glycosylasparaginase cDNA (pSVL/AGUAIa -Val). Cells transfected with the normal glycosylasparaginase cDNA had a 15-fold increase in GlcNAc-Asn cleaving activity over that of mock-transfected cells (Figure 4 ). In addition, Western-blot analysis revealed that the expressed protein was correctly processed to the heavy and light subunits that are known to compose the mature active glycosylasparaginase enzyme ( Figure  4 ) (Fisher et al., 1990; Fisher and Aronson, 199 la) . The 27 kDa and 24 kDa bands that were detected with antibodies raised against the heavy subunit are different proteolytic forms (H. Park, unpublished work). In marked contrast with cells expressing normal AGU, COS-1 cells transfected with pSVL/ AGUAla Val displayed no increase in GlcNAc-Asn cleaving activity or the processed heavy and light subunits (Figure 4) . Instead, the 46 kDa glycosylasparaginase precursor polypeptide was immunologically detected with both heavy-and lightsubunit-specific antibodies (Figure 4) . Only a minor amount of the 46 kDa uncleaved precursor was evident in cells transfected with pSVL/HPAsn.6. Immunofluorescent staining of COS-1 cells expressing the normal recombinant glycosylasparaginase protein revealed a punctate staining pattern that is typical for lysosomal localization (Figure 5a ) (Van Dongen et al., 1984; Hoefsloot et al., 1990 (Hreidarsson et al., 1983) . We have identified the molecular defect that causes AGU in patient TC79-886 to be a 5 bp deletion within the glycosylasparaginase-protein-coding region ( Figure  2 ). The primary effect of this mutation is a shift in reading frame that results in premature termination of translation. The predicted glycosylasparaginase product from TC79-886 is a truncated polypeptide of 118 amino-acid residues (13 kDa), after removal of the signal peptide, with the C-terminal 19 residues encoding an out-of-frame non-glycosylasparaginase protein segment (Figure 2c ). In terms of the native mature glycosylasparaginase structure, this mutant protein comprises only 67 % of the heavy subunit and lacks a light subunit. We expressed the protein product of AGUA7bP from patient TC79-886 in COS-1 cells and although a 13 kDa peptide was evident by Western blotting with heavy-subunit-specific antibodies, the level of expression was extremely low (results not shown). This might reflect increased susceptibility of the mutant protein to proteolytic degradation in vivo or a reduced antigenicity towards the heavysubunit antibodies. Enzyme assays conducted on the transfected COS-1 cell extract indicated that the truncated 13 kDa protein was not catalytically active (results not shown) as would be expected, since there is a loss of the entire light subunit whose Nterminal Thr-206 has been proposed to be an important activesite residue (Kaartinen et al., 1991) .
A possible secondary outcome of the American AGUA7bP mutation is that it reduces the stability of the transcribed mRNA. A Northern blot of RNA from patient TC79-886 revealed glycosylasparaginase mRNAs with a broad, smeared appearance ( Figure 1 ) suggesting that the mRNA is partially degraded. The relative quantity of glycosylasparaginase message determined in patient TC79-886 by PCR, using 28S rRNA as a standard, was also decreased compared with normal levels, and previously we found it necessary to increase by 5-fold the amount of cDNA template in order to achieve minimal ethidium bromide detection of the correct PCR product from the mid-region of TC79-886 (Fisher and Aronson, 199 la) . Further experiments are necessary to verify these suggestions that glycosylasparaginase mRNA expressed by American AGU-affected patient TC79-886 is less stable.
The other two AGU mutations that we have focused on in this study were identified in a British family with two AGU-afflicted male siblings J. A. and M. A. The original diagnosis was based on the presence of large quantities of aspartylglucosamine excreted in the urine of both probands. Enzyme assays were conducted on fibroblasts from the two probands revealing both J. A. and M. A. contained 1.1-3.8 ,l-units/mg of protein of GlcNAc-Asn cleaving activity compared with controls (n = 12) having a mlean of 108 #-units/ng of protein. Lysates from COS-1 cells transfected with either pSVL, pSVL/HPAsn.6 (Fisher et al., 1990; Fisher and Aronson, 1991 a) , or pSVL/AGUAIa -Val were resolved on a 15% (w/v) polyacrylamide gel and electrophoretically transferred to a membrane support. Lanes labelled H were incubated with heavy-subunit-specific antibodies, whereas lanes labelled L were incubated with lightsubunit-specific antibodies. Detection of the antibody-antigen complex was with a secondary alkaline phosphatase conjugate. An aliquot of the same lysates that were used for immunoblotting was also assayed for glycosylasparaginase activity and total protein. Enzyme assays were performed only once for each set of transfected cells, and the specific activity of each lysate is given in m-unit/mg of protein (nmol of GIcNAc released/min at 37°C per mg of protein). The sizes of immunologically detected proteins are given at the right. COS-1 cells transfected with either the normal human placental cDNA HPAsn.6 (a) (Fisher et al., 1990; Fisher and Aronson, 1991 b) (Aula et al., 1973 (Aula et al., , 1974 (Figure 3) . The maternal 7 bp deletion occurs near the 5'-end of the AGU coding region, causing a shift in the reading frame and premature translational termination. The impact of this mutation is similar to the American AGUA5b allele discussed earlier, yet results in an even more truncated glycosylasparaginase protein: a 21-aminoacid polypeptide whose C-terminal 11 residues are out-of-frame. Such a shortened protein sequence would be unlikely to be stable in vivo or enzymically active. Also similar to the American AGUA5bV mutation were results that suggested the British AGUA 7bp allele causes a decrease in mRNA stability. Specifically, the frequency of Ml 3 clones that were sequenced and found to contain the 7 bp deletion was significantly lower compared with Ml 3 clones carrying either the normal allele, in the case of the mother P.A., or the AG UA -Val allele, in the case ofthe probands J.A. and M.A. While this result could be due to peculiarities with the biology of M13 bacteriophage, it might also reflect a lower copy number ofmRNA encoding the AG UA 7b_p mutation resulting from mRNA instability.
The British paternal C -+ T point mutation causes a substitution of Ala-101 by Val in the heavy subunit of glycosylasparaginase. The two additional methyl groups in valine could interfere with protein folding; for example, Daopin et al. . (991) in studying the bacteriophage T4 lysozyme found an .Ala -+ Val mutation decreased the stability of the enzyme. This change was proposed to force apart residues that form an a helix, thus weakening many van der Waals interactions and hydrogen bonds that stabilize the wild-type structure. The mutant T4 enzyme still folds, which implies that structural changes are occurring to alleviate overlaps between the introduced methyl groups and the atoms in the surrounding residues. It is possible that potential helix-forming amino-acid residues about the substituted valine in the heavy subunit of glycosylasparaginase might not be able to accommodate the additional methyl groups, thereby preventing proper folding of the mutant enzyme. Indeed, immunofluorescent cell staining of COS-1 cells transfected with the paternal AGUAla -Val cDNA revealed the expressed protein was not transported to the lysosome (Figure 5 ), but instead exhibited a staining pattern that is consistent with ER localization (Van Dongen et al., 1984; Hoefsloot et al., 1990) . The failure to release secreted or organelle-bound proteins from the ER or other early compartments has been shown to be a consequence ofthe inability ofthe protein to achieve its correct conformational state (Yamamoto et al., 1986) . We have reported that the major Finnish AGU Cys-163 -+ Ser mutation similarly produces a protein that is not transported to the lysosome (Fisher and Aronson, 199 1a), presumably due to improper folding caused by the loss of a disulphide bridge.
In addition to being trapped in an extra-lysosomal structure, the British paternal AGUAla-+Val protein is neither catalytically active nor post-translationally processed to the heavy and light subunits that constitute the mature enzyme (Figure 4) . Interestingly, the biochemical phenotype caused by the British Ala-1Ol1 -+Val amino-acid substition is identical to that of the Finnish AGU Cys-163 -+ Ser substitution (Fisher and Aronson, 199 1a, b ). An African-American GTintrnS -TT splice-site point mutation also produces a protein, albeit truncated at the Cterminus, that is inactive and unprocessed (Fisher and Aronson,   I I I   I   6m Characterization of alleles causing aspartylglycosaminuria 741 1991b). We have now identified three different AGU mutations that affect lysosomal transport, subunit processing and catalytic activity, strongly suggesting that the three events are interrelated. It is very likely that for each mutation the failure to achieve the correct heavy/light subunit structure is the result of the mutant proteins not being transported from the ER to the lysosome. Post-translational processing is common among lysosomal enzymes and is believed to occur either en route to the lysosome or in the hydrolytic lysosomal environment. While these proteolytic modifications often appear to have no impact on enzyme activity, cathepsin D (Yonezawa et al., 1988) and the protective protein of 3-galactosidase and neuraminidase (Galjart et al., 1988) have evolved where cleavage of a specific peptide bond is an obligatory activation step. Thus, cathepsin D and the protective protein are true zymogens that become functional only after they are delivered to the lysosome. The same logic can be applied to glycosylasparaginase, to explain the loss of enzyme activity caused by the British and Finnish amino-acid substitutions in terms of an absence of subunit processing. In the case of the truncated African-American AGU protein, the loss of 33 amino-acid residues from the C-terminus is more likely to be the governing force.
Each of the three AGU mutations that we have addressed in this paper were found to be surrounded by sequences that suggest possible mechanisms to account for how the genetic alterations arose. The 5 bp deletion of American patient TC79-886 (ACACA) occurs in a region where a dinucleotide AC is repeated five times in tandem (TACAACACACACACCTTTT) (Figure 2) . As a result of the repetition, this region shows motifs of overlapping direct repeats and symmetrical elements, that can induce short gene deletions by slipped mispairing (Krawczak and Cooper, 1991) . The British maternal AGU allele involves a 7 bp sequence that is deleted from a site (CTTGGCCCTTTAAG) which contains a CTT direct repeat and a region of partial selfcomplementarity (CTT/AAG) (Figure 3) . The gene deletion could be caused by local primary and secondary DNA structure and the partial self-complementarity can permit sequencers to form misaligned secondary structure. The non-complementary portions of these structures then provide templates for frameshifts and short deletions through the removal of the unpaired bases by endonucleases. This event is followed by repair DNA synthesis (Krawczak and Cooper, 1991) . The British paternal C --T mutation is surrounded by a direct repeat of GTAGGA(C-302 --T)AGTAGGA which could increase the frequency of this particular transitional mutation (Krawczak and Cooper, 1991) . The transitional mutation is in agreement with the slipped mispairing mechanism between two direct repeats; however, it is not predicted if the repeat copies are aligned. Other factors such as local dNTP concentrations could be important (D. N. Cooper, personal communication).
In this study we have identified a new AGU allele which causes AGU from an American patient TC79-886 (AGU55bP) and demonstrated the inheritance of two previously reported AGU alleles from a British patient (AGUA 7bP and AGUAZa-aL). While the majority of known AGU cases afflict people of Finnish descent, due to a founder effect, the occurrence of two different mutations in a single British family with unrelated parents suggests AGU alleles giving rise to AGU may be more prevalent in the non-Finnish gene pool than presumed. Interestingly, the British paternal mutation has also been reported in a patient of Italian origin (Ikonen et al., 1991b) . Of the different variety of AGU mutations that have been characterized, those that create amino-acid substitutions (AGUCy8ser and AGUALa vG1) have provided great insight into the biochemistry of glycosylasparaginase. Both appear to affect folding of the precursor glycosylasparaginase protein based on the inability of the defective proteins to be transported from the ER or related compartments to the lysosome. This consequently prevents subunit maturation, which we have proposed to be necessary for catalytic activity (Fisher and Aronson, 1991a,b) . Therefore, the Finnish AGUcYS-Ser and British AGUAla Val amino-acid substitutions might cause glycosylasparaginase deficiency from two vantages, lysosomal targeting and/or catalytic activation.
